Apolipoprotein D Explained

Apolipoprotein D (ApoD) is a protein that in humans is encoded by the APOD gene.^{[1] [2] [3]} Unlike other lipoproteins, which are mainly produced in the liver, apolipoprotein D is mainly produced in the brain and testes.^[4] It is a 29 kDa glycoprotein discovered in 1963 as a component of the high-density lipoprotein (HDL) fraction of human plasma.^{[5] [6]} It is the major component of human mammary cyst fluid. The human gene encoding it was cloned in 1986 and the deduced protein sequence revealed that ApoD is a member of the lipocalin family, small hydrophobic molecule transporters.^[2] ApoD is 169 amino acids long, including a secretion peptide signal of 20 amino acids. It contains two glycosylation sites (aspargines 45 and 78) and the molecular weight of the mature protein varies from 20 to 32 kDa (see figure 1). The resolved tertiary structure shows that ApoD is composed of 8 anti-parallel β-strands forming a hydrophobic cavity capable of receiving different ligands.^{[7] [8]} ApoD also contains 5 cysteine residues, 4 of which are involved in intra-molecular disulfide bonds.

Function

Apolipoprotein D (ApoD) is a component of HDL that has no marked similarity to other apolipoprotein sequences. It has a high degree of homology to plasma retinol-binding protein and other members of the alpha 2 microglobulin protein superfamily of carrier proteins, also known as lipocalins. It is a glycoprotein of estimated molecular weight 33 KDa. Apo-D is closely associated with the enzyme lecithin-cholesterol acyltransferase (LCAT) - an enzyme involved in lipoprotein metabolism. ApoD has also been shown to be an important link in the transient interaction between HDL and low-density lipoprotein (LDL) particles and between HDL particles and cells.^[9]

Interactions and ligands

ApoD was shown to bind steroid hormones such as progesterone and pregnenolone with a relatively strong affinity, and to estrogens with a weaker affinity.^{[10] [11]} Molecular modeling studies identified bilirubin, a breakdown product of heme, as a potential ligand. Arachidonic acid (AA) was identified as an ApoD ligand with a much better affinity than that of progesterone or pregnenolone.^[12] AA is the precursor of prostaglandins and leukotrienes, molecules that are involved in inflammation, platelet aggregation and cellular regulation.^[13] A very poor binding between ApoD and cholesterol has also been observed.^[14] Other ApoD ligands include E-3-methyl-2-hexenoic acid, a scent molecule present in body odor secretions;^[15] retinoic acid, which is involved in cellular differentiation; and sphingomyelin and sphingolipids, which are major components of HDL and cell membranes.^[16] The fact that apoD may bind such a large variety of ligands strongly support the hypothesis that it could be a multi-ligand, multi-functional protein.

Clinical significance

APOD is a biomarker of androgen insensitivity syndrome (AIS). APOD is an androgen up-regulated gene in normal scrotal fibroblast cells in comparison to labia majora cells in females with complete AIS (CAIS).^[17] APOD is associated with neurological disorders and nerve injury, especially related to myelin sheath. APOD was shown to be elevated in a rat model of stroke. APOD is elevated in patients with schizophrenia, bipolar disorder, and Alzheimer's disease.

ApoD expression in cells and tissues

Analysis of the ApoD gene promoter region identified a large number of promoter regulatory elements, among which are response elements to steroids (such as estrogen and progesterone) and glucocorticoids. Response elements to fatty acids, acute phase proteins, serum, and to the immune factor NF-κB were also observed.^{[18] [19] [20]} The presence of such a large number of regulatory sequences suggests that the regulation of its expression is very complex.

ApoD has been identified in 6 mammalian species as well as in chickens,^{[21] [22]} fruit flies,^[23] plants^[24] and bacteria.^[25] In humans, monkeys, rabbits and guinea pigs, ApoD is highly expressed in the nervous system (brain, cerebellum, and peripheral nerves). Otherwise, expression levels of ApoD vary largely from organ to organ and species to species, with humans displaying the most diverse expression of ApoD, and mice and rats almost exclusively expressing ApoD in the nervous system (see Figure 2). ApoD concentration in human plasma varies between 5 and 23 mg/100 ml.^[26] In the nervous system, the ApoD mRNA is expressed by fibroblasts, astrocytes and oligodendrocytes^{[27] [28] [29]} As a glycoprotein with a peptide signal, ApoD is secreted. Yet it can also be actively reinternalized. The transmembrane glycoprotein Basigin (BSG; CD147) was identified as an ApoD receptor.^[30] BSG is a membrane glycoprotein receptor, a member of the immunoglobulin family, involved in several pathologies such as cancer and Alzheimer's disease.^[31]

Modulation of ApoD expression

Studies on several cell types have shown that ApoD expression can be induced by several stressing situations such as growth arrest, senescence, oxidative and inflammatory stresses. ApoD expression is also increased in several neuropathologies. ApoD expression is modulated in several pathologies such as HDL familial deficiency, Tangier disease,^{[32] [33]} LCAT familial deficit^[34] and type 2 diabetes.^[35] It is overexpressed in numerous cancers,^[36] including breast,^{[37] [38]} ovary, prostate,^[39] skin^{[40] [41]} and central nervous system (CNS) cancer. In many cases, its expression is correlated with highly differentiated, non-invasive and non-metastatic state.

A role in lipid metabolism has been identified for ApoD by a study on transgenic (Tg) mice overexpressing human ApoD in the CNS.^[42] These mice slowly develop a hepatic and muscular steatosis accompanied with insulin resistance. However, none of the Tg mice develop obesity nor diabetes. ApoD induced lipid accumulation is not due to de novo lipogenesis but rather from increased lipid uptake in response to prostaglandin overproduction.^[43]

Plasma ApoD levels decrease significantly during normal uncomplicated pregnancy. ApoD is further decreased in women with excessive gestational weight gain and their newborns. In these women, the ApoD concentration was tightly associated with the lipid parameters.^[44] In morbidly obese women (BMI over 40) adipose tissues, ApoD protein expression is positively correlated with parameters of metabolic health.ApoD-null female mice (mice in which the ApoD gene was inactivated) present progressive (up to 50%) bone volume reduction with aging.^[45]

ApoD and the nervous system

Both ApoD and Apolipoprotein E (ApoE) protein levels increase drastically at the site of regeneration following a nerve crush injury in the rat.^{[46] [47]} Similar observations have been made in rabbits, marmoset monkeys and in mice.^[48] Elevated levels of ApoD were observed in the cerebrospinal fluid, hippocampus and cortex of human patients with Alzheimer's disease, cerebrovascular disease, motoneuron disease, meningoencephalitis and stroke.^[49] ApoD expression is altered in plasma and post-mortem brains of patients with schizophrenia.^[50] In patients with Parkinson's disease or with multiple sclerosis, ApoD expression is strongly increased in glial cells of the substantia nigra.^{[51] [52]}

Niemann-Pick type C (NPC) is a genetic disorder affecting cholesterol transport that is accompanied by chronic progressive neurodegeneration. In animal models of NPC, ApoD expression is increased in the plasma and the brain.^[53] In rats, ApoD expression increases in the hippocampus after enthorinal cortex lesioning. ApoD mRNA and protein increases in the ipsilateral region of hippocampus as early as 2 days post-lesion (DPL), remains high for 10 days and returns to normal after 14 DPL, a period considered necessary for a complete reinervation.^[54] Similar results are obtained after injection of kainic acid, an analog of glutamic acid which causes a severe neurodegenerative injury in the hippocampus^[55] or after experimentally-induced stoke.^{[56] [57]} ApoD expression is also increased in the aging brain. Altogether, these data suggest that ApoD plays an important role in neural preservation and protection.

Tg mice are less sensitive to oxidative stress induced by paraquat, a free oxygen radical generator, and present reduced lipid peroxidation levels. In contrast, apoD-null mice show increased sensitivity to oxidative stress, increased brain lipid peroxidation and impaired locomotor and learning abilities. Similar results have been observed in a drosophila model.^[58] Mice infected with the human coronavirus OC43 develop encephalitis and inflammatory demyelination of the CNS, a disease very similar to multiple sclerosis. Tg mice infected with OC43 display increased survivability compared to control animals.^[59] Tg mice treated with kainic acid show a significant reduction of inflammatory responses and a much stronger protection against apoptosis in the hippocampus than control animals.^[60] ApoD-null mice crossed with APP-PS1 mice, a mouse model of Alzheimer's disease, displayed a 2-fold increase of hippocampal amyloid plaque load. In contrast, the progeny of Tg mice crossed with APP-PS1 mice displayed reduced hippocampal plaque load by 35%, and a 35% to 65% reduction of amyloid peptide levels.^[61]

Further reading

• Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R . Apolipoprotein D . Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1482 . 1–2 . 185–98 . October 2000 . 11058760 . 10.1016/S0167-4838(00)00162-X . 8189847 .
• Peitsch MC, Boguski MS . Is apolipoprotein D a mammalian bilin-binding protein? . The New Biologist . 2 . 2 . 197–206 . February 1990 . 2083249 .
• Balbín M, Freije JM, Fueyo A, Sánchez LM, López-Otín C . Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease . The Biochemical Journal . 271 . 3 . 803–7 . November 1990 . 2244881 . 1149635 . 10.1042/bj2710803 .
• Drayna D, Scott JD, Lawn R . Multiple RFLPs at the human apolipoprotein D (APOD) locus . Nucleic Acids Research . 15 . 22 . 9617 . November 1987 . 2891117 . 306509 . 10.1093/nar/15.22.9617 .
• Fielding PE, Fielding CJ . A cholesteryl ester transfer complex in human plasma . Proceedings of the National Academy of Sciences of the United States of America . 77 . 6 . 3327–30 . June 1980 . 6774335 . 349608 . 10.1073/pnas.77.6.3327 . 1980PNAS...77.3327F . free .
• Schindler PA, Settineri CA, Collet X, Fielding CJ, Burlingame AL . Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion . Protein Science . 4 . 4 . 791–803 . April 1995 . 7613477 . 2143102 . 10.1002/pro.5560040419 .
• Yang CY, Gu ZW, Blanco-Vaca F, Gaskell SJ, Yang M, Massey JB, Gotto AM, Pownall HJ . Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links . Biochemistry . 33 . 41 . 12451–5 . October 1994 . 7918467 . 10.1021/bi00207a011 .
• Holzfeind P, Merschak P, Dieplinger H, Redl B . The human lacrimal gland synthesizes apolipoprotein D mRNA in addition to tear prealbumin mRNA, both species encoding members of the lipocalin superfamily . Experimental Eye Research . 61 . 4 . 495–500 . October 1995 . 8549691 . 10.1016/S0014-4835(05)80145-9 .
• Zeng C, Spielman AI, Vowels BR, Leyden JJ, Biemann K, Preti G . A human axillary odorant is carried by apolipoprotein D . Proceedings of the National Academy of Sciences of the United States of America . 93 . 13 . 6626–30 . June 1996 . 8692868 . 39076 . 10.1073/pnas.93.13.6626 . 1996PNAS...93.6626Z . free .
• Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES . Characterization of single-nucleotide polymorphisms in coding regions of human genes . Nature Genetics . 22 . 3 . 231–8 . July 1999 . 10391209 . 10.1038/10290 . 195213008 .
• Liu Z, Chang GQ, Leibowitz SF . Apolipoprotein D interacts with the long-form leptin receptor: a hypothalamic function in the control of energy homeostasis . FASEB Journal . 15 . 7 . 1329–31 . May 2001 . 11344130 . 10.1096/fj.00-0530fje . free . 14390285 .
• Sánchez D, Ganfornina MD, Martínez S . Expression pattern of the lipocalin apolipoprotein D during mouse embryogenesis . Mechanisms of Development . 110 . 1–2 . 225–9 . January 2002 . 11744388 . 10.1016/S0925-4773(01)00578-0 . 17460139 . free . 10261/307861 . free .
• Mahadik SP, Khan MM, Evans DR, Parikh VV . Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome . Schizophrenia Research . 58 . 1 . 55–62 . November 2002 . 12363390 . 10.1016/S0920-9964(01)00378-4 . 22634600 .
• Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madan A, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ, Marra MA . Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences . Proceedings of the National Academy of Sciences of the United States of America . 99 . 26 . 16899–903 . December 2002 . 12477932 . 139241 . 10.1073/pnas.242603899 . 2002PNAS...9916899M . free .
• Desai PP, Hendrie HC, Evans RM, Murrell JR, DeKosky ST, Kamboh MI . Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans . American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics . 116B . 1 . 98–101 . January 2003 . 12497622 . 10.1002/ajmg.b.10798 . 25171300 .
• Kang MK, Kameta A, Shin KH, Baluda MA, Kim HR, Park NH . Senescence-associated genes in normal human oral keratinocytes . Experimental Cell Research . 287 . 2 . 272–81 . July 2003 . 12837283 . 10.1016/S0014-4827(03)00061-2 .
• Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN . Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype . Biological Psychiatry . 54 . 2 . 136–41 . July 2003 . 12873803 . 10.1016/S0006-3223(02)01976-5 . 46158571 .

External links

• • Applied Research on Apolipoproteins

Notes and References

1. Drayna DT, McLean JW, Wion KL, Trent JM, Drabkin HA, Lawn RM . Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily . DNA . 6 . 3 . 199–204 . June 1987 . 2439269 . 10.1089/dna.1987.6.199 .
2. Drayna D, Fielding C, McLean J, Baer B, Castro G, Chen E, Comstock L, Henzel W, Kohr W, Rhee L . Cloning and expression of human apolipoprotein D cDNA . The Journal of Biological Chemistry . 261 . 35 . 16535–9 . December 1986 . 10.1016/S0021-9258(18)66599-8 . 3453108 . free .
3. Web site: Entrez Gene: APOD apolipoprotein D.
4. Muffat J, Walker DW . Apolipoprotein D: an overview of its role in aging and age-related diseases . Cell Cycle . 9 . 2 . 269–73 . January 2010 . 20023409 . 3691099 . 10.4161/cc.9.2.10433 .
5. Ayrault Jarrier M, Levy G, Polonovski J . [Study of Human Serum Alpha-Lipoproteins by Immunoelectrophoresis] . Bulletin de la Société de Chimie Biologique . 45 . 703–13 . August 1963 . 14051455 .
6. McConathy WJ, Alaupovic P . Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma . Biochemistry . 15 . 3 . 515–20 . February 1976 . 56198 . 10.1021/bi00648a010 .
7. Peitsch MC, Boguski MS . Is apolipoprotein D a mammalian bilin-binding protein? . The New Biologist . 2 . 2 . 197–206 . February 1990 . 2083249 .
8. Eichinger A, Nasreen A, Kim HJ, Skerra A . Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D . The Journal of Biological Chemistry . 282 . 42 . 31068–75 . October 2007 . 17699160 . 10.1074/jbc.M703552200 . 9647650 . free .
9. Braesch-Andersen S, Beckman L, Paulie S, Kumagai-Braesch M . ApoD mediates binding of HDL to LDL and to growing T24 carcinoma . PLOS ONE . 9 . 12 . e115180 . December 2014 . 25513803 . 4267786 . 10.1371/journal.pone.0115180 . 2014PLoSO...9k5180B . free .
10. Pearlman WH, Guériguian JL, Sawyer ME . A specific progesterone-binding component of human breast cyst fluid . The Journal of Biological Chemistry . 248 . 16 . 5736–41 . August 1973 . 10.1016/S0021-9258(19)43566-7 . 4723913 . free .
11. Lea OA . Binding properties of progesterone-binding Cyst protein, PBCP . Steroids . 52 . 4 . 337–8 . October 1988 . 3250014 . 10.1016/0039-128x(88)90135-3 . 26492300 .
12. Morais Cabral JH, Atkins GL, Sánchez LM, López-Boado YS, López-Otin C, Sawyer L . Arachidonic acid binds to apolipoprotein D: implications for the protein's function . FEBS Letters . 366 . 1 . 53–6 . June 1995 . 7789516 . 10.1016/0014-5793(95)00484-q . 9063157 . free .
13. Kuehl FA . Jr . Egan . RW . Prostaglandins, arachidonic acid, and inflammation . Science . 28 November 1980 . 210 . 4473 . 978–84 . 10.1126/science.6254151 . 6254151. 1980Sci...210..978K .
14. Patel RC, Lange D, McConathy WJ, Patel YC, Patel SC . Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy . Protein Engineering . 10 . 6 . 621–5 . June 1997 . 9278274 . 10.1093/protein/10.6.621 . free .
15. Zeng C, Spielman AI, Vowels BR, Leyden JJ, Biemann K, Preti G . A human axillary odorant is carried by apolipoprotein D . Proceedings of the National Academy of Sciences of the United States of America . 93 . 13 . 6626–30 . June 1996 . 8692868 . 10.1073/pnas.93.13.6626 . 39076 . 1996PNAS...93.6626Z . free .
16. Breustedt DA, Schönfeld DL, Skerra A . Comparative ligand-binding analysis of ten human lipocalins . Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764 . 2 . 161–73 . February 2006 . 16461020 . 10.1016/j.bbapap.2005.12.006 .
17. Appari M, Werner R, Wünsch L, Cario G, Demeter J, Hiort O, Riepe F, Brooks JD, Holterhus PM . Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome . Journal of Molecular Medicine . 87 . 6 . 623–32 . June 2009 . 19330472 . 5518750 . 10.1007/s00109-009-0462-3 .
18. Lambert . J . Provost . PR . Marcel . YL . Rassart . E . Structure of the human apolipoprotein D gene promoter region . Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 20 February 1993 . 1172 . 1–2 . 190–2 . 10.1016/0167-4781(93)90292-l . 7916629.
19. Do Carmo . S . Séguin . D . Milne . R . Rassart . E . Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter . The Journal of Biological Chemistry . 15 February 2002 . 277 . 7 . 5514–23 . 10.1074/jbc.M105057200 . 11711530. 45692527 . free .
20. Do Carmo . S . Levros LC . Jr . Rassart . E . Modulation of apolipoprotein D expression and translocation under specific stress conditions . Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. June 2007 . 1773 . 6 . 954–69 . 10.1016/j.bbamcr.2007.03.007 . 17477983. free .
21. Vieira . AV . Lindstedt . K . Schneider . WJ . Vieira . PM . Identification of a circulatory and oocytic avian apolipoprotein D . Molecular Reproduction and Development . December 1995 . 42 . 4 . 443–6 . 10.1002/mrd.1080420411 . 8607974. 34209685 .
22. Ganfornina . MD . Sánchez . D . Pagano . A . Tonachini . L . Descalzi-Cancedda . F . Martínez . S . Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins . Developmental Dynamics. January 2005 . 232 . 1 . 191–9 . 10.1002/dvdy.20193 . 15580625. 14396229 . free .
23. Sánchez . D . Ganfornina . MD . Torres-Schumann . S . Speese . SD . Lora . JM . Bastiani . MJ . Characterization of two novel lipocalins expressed in the Drosophila embryonic nervous system . The International Journal of Developmental Biology . June 2000 . 44 . 4 . 349–59 . 10949044.
24. Frenette Charron . JB . Breton . G . Badawi . M . Sarhan . F . Molecular and structural analyses of a novel temperature stress-induced lipocalin from wheat and Arabidopsis. FEBS Letters . 24 April 2002 . 517 . 1–3 . 129–32 . 10.1016/s0014-5793(02)02606-6 . 12062422. 34705682 .
25. Bishop . RE . Penfold . SS . Frost . LS . Höltje . JV . Weiner . JH . Stationary phase expression of a novel Escherichia coli outer membrane lipoprotein and its relationship with mammalian apolipoprotein D. Implications for the origin of lipocalins . The Journal of Biological Chemistry . 29 September 1995 . 270 . 39 . 23097–103 . 10.1074/jbc.270.39.23097 . 7559452. 2904679 . free .
26. Camato . R . Marcel . YL . Milne . RW . Lussier-Cacan . S . Weech . PK . Protein polymorphism of a human plasma apolipoprotein D antigenic epitope . Journal of Lipid Research . June 1989 . 30 . 6 . 865–75 . 10.1016/S0022-2275(20)38304-8 . 2477480. free .
27. Smith . KM . Lawn . RM . Wilcox . JN . Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization . Journal of Lipid Research . June 1990 . 31 . 6 . 995–1004 . 10.1016/S0022-2275(20)42739-7 . 2373967. free .
28. Provost . PR . Marcel . YL . Milne . RW . Weech . PK . Rassart . E . Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures . FEBS Letters . 23 September 1991 . 290 . 1–2 . 139–41 . 10.1016/0014-5793(91)81244-3 . 1915865. 20185401 . free .
29. Provost . PR . Villeneuve . L . Weech . PK . Milne . RW . Marcel . YL . Rassart . E . Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization . Journal of Lipid Research . December 1991 . 32 . 12 . 1959–70 . 10.1016/S0022-2275(20)41899-1 . 1816324. free .
30. Najyb . O . Brissette . L . Rassart . E . Apolipoprotein D Internalization Is a Basigin-dependent Mechanism . The Journal of Biological Chemistry . 26 June 2015 . 290 . 26 . 16077–87 . 10.1074/jbc.M115.644302 . 25918162. 4481210 . free .
31. Iacono . KT . Brown . AL . Greene . MI . Saouaf . SJ . CD147 immunoglobulin superfamily receptor function and role in pathology . Experimental and Molecular Pathology . December 2007 . 83 . 3 . 283–95 . 10.1016/j.yexmp.2007.08.014 . 17945211. 2211739 .
32. Bodzioch . M . Orsó . E . Klucken . J . Langmann . T . Böttcher . A . Diederich . W . Drobnik . W . Barlage . S . Büchler . C . Porsch-Ozcürümez . M . Kaminski . WE . Hahmann . HW . Oette . K . Rothe . G . Aslanidis . C . Lackner . KJ . Schmitz . G . The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease . Nature Genetics . August 1999 . 22 . 4 . 347–51 . 10.1038/11914 . 10431237. 26890624 .
33. Alaupovic . P . Schaefer . EJ . McConathy . WJ . Fesmire . JD . Brewer HB . Jr . Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease) . Metabolism: Clinical and Experimental . August 1981 . 30 . 8 . 805–9 . 10.1016/0026-0495(81)90027-5 . 6790903.
34. Albers . JJ . Adolphson . J . Chen . CH . Murayama . N . Honma . S . Akanuma . Y . Defective enzyme causes lecithin-cholesterol acyltransferase deficiency in a Japanese kindred . Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 9 July 1985 . 835 . 2 . 253–7 . 10.1016/0005-2760(85)90280-2 . 4005283.
35. Baker . WA . Hitman . GA . Hawrami . K . McCarthy . MI . Riikonen . A . Tuomilehto-Wolf . E . Nissinen . A . Tuomilehto . J . Mohan . V . Viswanathan . M . Apolipoprotein D gene polymorphism: a new genetic marker for type 2 diabetic subjects in Nauru and south India . Diabetic Medicine . December 1994 . 11 . 10 . 947–52 . 10.1111/j.1464-5491.1994.tb00252.x . 7895459. 24833816 .
36. Ryu . B . Jones . J . Hollingsworth . MA . Hruban . RH . Kern . SE . Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers . Cancer Research . 1 March 2001 . 61 . 5 . 1833–8 . 11280733.
37. Díez-Itza . I . Vizoso . F . Merino . AM . Sánchez . LM . Tolivia . J . Fernández . J . Ruibal . A . López-Otín . C . Expression and prognostic significance of apolipoprotein D in breast cancer . The American Journal of Pathology . February 1994 . 144 . 2 . 310–20 . 8311115. 1887137 .
38. Søiland . H . Skaland . I . Varhaug . JE . Kørner . H . Janssen . EA . Gudlaugsson . E . Baak . JP . Søreide . JA . Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients . Acta Oncologica . 2009 . 48 . 4 . 514–21 . 10.1080/02841860802620613 . 19107621. 22404040 . free .
39. Aspinall . JO . Bentel . JM . Horsfall . DJ . Haagensen . DE . Marshall . VR . Tilley . WD . Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues . The Journal of Urology . August 1995 . 154 . 2 Pt 1 . 622–8 . 10.1097/00005392-199508000-00082 . 7541868.
40. Miranda . E . Vizoso . F . Martín . A . Quintela . I . Corte . MD . Seguí . ME . Ordiz . I . Merino . AM . Apolipoprotein D expression in cutaneous malignant melanoma . Journal of Surgical Oncology . June 2003 . 83 . 2 . 99–105 . 10.1002/jso.10245 . 12772203. 25700567 .
41. West . RB . Harvell . J . Linn . SC . Liu . CL . Prapong . W . Hernandez-Boussard . T . Montgomery . K . Nielsen . TO . Rubin . BP . Patel . R . Goldblum . JR . Brown . PO . van de Rijn . M . Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans . The American Journal of Surgical Pathology . August 2004 . 28 . 8 . 1063–9 . 10.1097/01.pas.0000126857.86186.4c . 15252314. 5773777 .
42. Do Carmo . S . Fournier . D . Mounier . C . Rassart . E . Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism . American Journal of Physiology. Endocrinology and Metabolism . April 2009 . 296 . 4 . E802-11 . 10.1152/ajpendo.90725.2008 . 19176353.
43. Desmarais . F . Bergeron . KF . Rassart . E . Mounier . C . Apolipoprotein D overexpression alters hepatic prostaglandin and omega fatty acid metabolism during the development of a non-inflammatory hepatic steatosis . Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. April 2019 . 1864 . 4 . 522–531 . 10.1016/j.bbalip.2019.01.001 . 30630053. 58594626 .
44. Do Carmo . S . Forest . JC . Giguère . Y . Masse . A . Lafond . J . Rassart . E . Modulation of Apolipoprotein D levels in human pregnancy and association with gestational weight gain . Reproductive Biology and Endocrinology . 2 September 2009 . 7 . 92 . 10.1186/1477-7827-7-92 . 19723339. 3224896 . free .
45. Martineau . C . Najyb . O . Signor . C . Rassart . É . Moreau . R . Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice . Metabolism: Clinical and Experimental . September 2016 . 65 . 9 . 1247–58 . 10.1016/j.metabol.2016.05.007 . 27506732. 7094319 .
46. Boyles . JK . Notterpek . LM . Anderson . LJ . Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I . The Journal of Biological Chemistry . 15 October 1990 . 265 . 29 . 17805–15 . 10.1016/S0021-9258(18)38235-8 . 2120218. free .
47. Boyles . JK . Notterpek . LM . Wardell . MR . Rall SC . Jr . Identification, characterization, and tissue distribution of apolipoprotein D in the rat . Journal of Lipid Research . December 1990 . 31 . 12 . 2243–56 . 10.1016/S0022-2275(20)42112-1 . 2090718. free .
48. Ganfornina . MD . Do Carmo . S . Martínez . E . Tolivia . J . Navarro . A . Rassart . E . Sanchez . D . ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury . Glia . 15 August 2010 . 58 . 11 . 1320–34 . 10.1002/glia.21010 . 20607718. 7165554 .
49. Terrisse . L . Poirier . J . Bertrand . P . Merched . A . Visvikis . S . Siest . G . Milne . R . Rassart . E . Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients . Journal of Neurochemistry . October 1998 . 71 . 4 . 1643–50 . 10.1046/j.1471-4159.1998.71041643.x . 9751198. 24675226 . free .
50. Thomas . EA . Dean . B . Pavey . G . Sutcliffe . JG . Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders . Proceedings of the National Academy of Sciences of the United States of America . 27 March 2001 . 98 . 7 . 4066–71 . 10.1073/pnas.071056198 . 11274430. 31180 . 2001PNAS...98.4066T . free .
51. Reindl . M . Knipping . G . Wicher . I . Dilitz . E . Egg . R . Deisenhammer . F . Berger . T . Increased intrathecal production of apolipoprotein D in multiple sclerosis . Journal of Neuroimmunology . 1 October 2001 . 119 . 2 . 327–32 . 10.1016/s0165-5728(01)00378-2 . 11585636. 24583456 .
52. Ordoñez . C . Navarro . A . Perez . C . Astudillo . A . Martínez . E . Tolivia . J . Apolipoprotein D expression in substantia nigra of Parkinson disease . Histology and Histopathology . April 2006 . 21 . 4 . 361–6 . 10.14670/HH-21.361 . 16437381.
53. Yoshida . K . Cleaveland . ES . Nagle . JW . French . S . Yaswen . L . Ohshima . T . Brady . RO . Pentchev . PG . Kulkarni . AB . Molecular cloning of the mouse apolipoprotein D gene and its upregulated expression in Niemann-Pick disease type C mouse model . DNA and Cell Biology . October 1996 . 15 . 10 . 873–82 . 10.1089/dna.1996.15.873 . 8892759.
54. Terrisse . L . Séguin . D . Bertrand . P . Poirier . J . Milne . R . Rassart . E . Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion . Brain Research. Molecular Brain Research . 18 June 1999 . 70 . 1 . 26–35 . 10.1016/s0169-328x(99)00123-0 . 10381540.
55. Ong . WY . He . Y . Suresh . S . Patel . SC . Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus . Neuroscience . July 1997 . 79 . 2 . 359–67 . 10.1016/s0306-4522(96)00608-2 . 9200721. 11857861 .
56. Rickhag . M . Wieloch . T . Gidö . G . Elmér . E . Krogh . M . Murray . J . Lohr . S . Bitter . H . Chin . DJ . von Schack . D . Shamloo . M . Nikolich . K . Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue . Journal of Neurochemistry . January 2006 . 96 . 1 . 14–29 . 10.1111/j.1471-4159.2005.03508.x . 16300643. 23231070 . free .
57. Rickhag . M . Deierborg . T . Patel . S . Ruscher . K . Wieloch . T . Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment . Journal of Cerebral Blood Flow and Metabolism. March 2008 . 28 . 3 . 551–62 . 10.1038/sj.jcbfm.9600552 . 17851453. 25611779 . free .
58. Ganfornina . MD . Do Carmo . S . Lora . JM . Torres-Schumann . S . Vogel . M . Allhorn . M . González . C . Bastiani . MJ . Rassart . E . Sanchez . D . Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress . Aging Cell . August 2008 . 7 . 4 . 506–15 . 10.1111/j.1474-9726.2008.00395.x . 18419796. 2574913 .
59. Do Carmo . S . Jacomy . H . Talbot . PJ . Rassart . E . Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice . The Journal of Neuroscience. 8 October 2008 . 28 . 41 . 10330–8 . 10.1523/JNEUROSCI.2644-08.2008 . 18842892. 6671015 .
60. Najyb . O . Do Carmo . S . Alikashani . A . Rassart . E . Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice . Molecular Neurobiology . August 2017 . 54 . 6 . 3948–3963 . 10.1007/s12035-016-9920-4 . 27271124. 7091089 .
61. Li . H . Ruberu . K . Muñoz . SS . Jenner . AM . Spiro . A . Zhao . H . Rassart . E . Sanchez . D . Ganfornina . MD . Karl . T . Garner . B . Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice . Neurobiology of Aging . May 2015 . 36 . 5 . 1820–33 . 10.1016/j.neurobiolaging.2015.02.010 . 25784209. 15335129 .